Add-on Acquisition • Internet Software and Services

Medtronic Acquires Nutrino

On November 21, 2018, Medtronic acquired internet software and services company Nutrino

Acquisition Context
  • This is Medtronic’s 1st transaction in the Internet Software and Services sector.
  • This is Medtronic’s 3rd transaction in Israel.

Explore All 10210 Add-on Acquisition Internet Software and Services Deals - Search the Database Free


M&A Deal Summary

Date November 21, 2018
Target Nutrino
Sector Internet Software and Services
Buyer(s) Medtronic
Deal Type Add-on Acquisition

Target Company

Nutrino

Tel Aviv, Israel
Nutrino, Inc. is a provider of nutrition-related data services, analytics, and technologies. Nutrino uncovers the invisible connections between people and food to empower better nutritional decisions for better health outcomes. Nutrino, Inc. was founded in 2011 and is based in Tel Aviv, Israel.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Medtronic

Galway, Ireland

Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 33.5B USD (2025)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Galway, Ireland with its operational headquarters in Fridley, Minnesota.


Deal Context for Buyer #
Overall 49 of 59
Sector: Internet Software and Services 1 of 1
Type: Add-on Acquisition 47 of 57
Country: Israel 3 of 3
Year: 2018 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-20 Mazor Robotics

Caesarea, Israel

Mazor Robotics Ltd. is an Israeli maker of guidance systems for spine and brain surgeries. Company introduced the Renaissance system and in 2016 launched the next generation Mazor X system. To date, more than 200 Mazor systems are in clinical use on four continents and have guided the placement of more than 250,000 implants during some 40,000 procedures, enabling minimally-invasive spine surgery to become standard procedure in many hospitals. Mazor's core technology has received more than 15 U.S. Food and Drug Administration clearances and has been the subject of more than 60 publications, leading the spine robotics market on the evidence front. Mazor is the holder of more than fifty patents worldwide.

Buy $1.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-24 EPIX Therapeutics

Santa Clara, California, United States

EPIX Therapeutics, Inc. is a medical device company that designs and manufactures a novel, catheter-based, temperature-controlled cardiac ablation system for the treatment of patients with cardiac arrhythmias (irregular heartbeats), including atrial fibrillation (AF). EPIX Therapeutics, Inc. was founded in 2007 and is based in Santa Clara, California.

Buy -